Cited by 29Blood Pressure and Hypertension StudiesSodium Intake and HealthClinical practice guidelines implementation

Evidence-based Diuretics: Focus On Chlorthalidone and Indapamide

DiNicolantonio, James J, Bhutani, Jaikrit, Lavie, Carl J, O’Keefe, James H·2015·Future Cardiology

Abstract

Thiazide and thiazide-like diuretics are cornerstone treatments for hypertension. However, unlike chlorthalidone (CTD) and indapamide (IDP), hydrochlorothiazide (HCTZ) lacks evidence for reducing morbidity and mortality as monotherapy compared with placebo or control. Despite this fact, HCTZ is prescribed much more frequently than CTD or IDP. We believe that all hypertension guidelines should follow the National Institute for Health and Excellence (NICE) and make IDP and CTD first choice 'thiazide-like diuretics.' This article will focus on the available evidence pertaining to HCTZ versus CTD and IDP. We will review the pharmacological differences between these three diuretics, as well as the clinical trial data and important side effects.

Integrity signals

Registry

Crossref · 10.2217/fca.14.83

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
DiNicolantonio, J. J., Bhutani, J., Lavie, C. J., & O’Keefe, J. H.
Affiliations
  • Saint Luke's Hospital (US)
  • Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (IN)
  • Pennington Biomedical Research Center (US)
Venue
Future Cardiology
Published
2015-03
Volume
11
Issue
2
Pages
203-217
ISSN
  • 1479-6678 (ISSN-L)
  • 1744-8298
OpenAlex
W2076448578
Cited by
29
References
105
Citations by year
2026: 3 · 2025: 2 · 2024: 4 · 2022: 3 · 2021: 2 · 2020: 7 · 2019: 2 · 2018: 4 · 2017: 1 · 2014: 1
FWCI
0.29
Type
journal article
Language
en
Open access
closed
Locations
  • Future Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords
chlorthalidone, indapamide, hydrochlorothiazide, thiazide-like diuretics, antihypertensive therapy, antihypertensive monotherapy, NICE guidelines, adverse effects, morbidity and mortality
MeSH terms
Antihypertensive Agents, Chlorthalidone, Diuretics, Humans, Hydrochlorothiazide, Hypertension, Indapamide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review